Stage IV Cutaneous Melanoma AJCC v6 and v7
Oncology
Prevalence
75.0 / 100K
Incidence
23.0 / 100K/yr
0 drugs in development·0 companies·2 clinical trials
Frequently asked questions
How many clinical trials target Stage IV Cutaneous Melanoma AJCC v6 and v7?
There are 2 clinical trials targeting Stage IV Cutaneous Melanoma AJCC v6 and v7 tracked by BioSniper.
What is the prevalence of Stage IV Cutaneous Melanoma AJCC v6 and v7?
The estimated prevalence of Stage IV Cutaneous Melanoma AJCC v6 and v7 is approximately 75.0 per 100,000 population.
Deep-dive into Stage IV Cutaneous Melanoma AJCC v6 and v7
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis